The creation of these training modules to assist school staff and children with Type 1 was initially facilitated in 2017 by voluntary work performed by Peter Goss. Chair APS Diabetes Committee, Jenny Goss CDE, Megan Paterson CDE, Darrell Price FRACP, Leone Gray FRACP, Deb Foskett CDE, Kirrily Chambers CDE, Jess O'Shannassy CDE and Anton Harding FRACP. Clinical advice was also gratefully received from Bruce King FRACP, Carmel Smart PhD, Peter Adolfsson MD PhD, Jerry Wales MD, Joe Solowiejczyk DE and Charlotte Goss BA M.Teach.
This initiative was supported by community partners, Lou's Legacy (Lucy Nicholls) and the Type 1 Foundation, (Ange McCaughley, Sarah Gocentis, Rebecca Broekman, Jo Manderson, Allan Houliston, Tanya Carroll, Michelle Dickens and Michelle Winkle). We have been assisted by a grant from the Geelong Community Foundation and acknowledge the Australian Paediatric Society for ongoing support. We have had invaluable support ongoing from consumer representatives Tamara Boyer and Lorraine Pitman and CDEs Lucy Casson and Nicola Hamood.
We gratefully acknowledge ISPAD, our world child diabetes leaders for their genuine advocacy for children and families with T1D by endorsing these modules and therefore aiming for best possible outcomes for those living with T1D! ISPAD was wise in seeking legal validation of both Position Statements. So Arnold Bloch Leibler’s contribution, particularly through Peter Seidel and Bridget Cowling, has been of exceptional value in providing independent, international-grade legal validation of the ISPAD Position Statements on the management of Type 1 diabetes in schools. Their work ensured that the Statements were not only clinically authoritative but also legally robust across jurisdictions, grounded in contemporary principles of workplace health and safety law, duty of care, human rights, and reasonable practicability.
By stress-testing the guidance against real case law, regulatory frameworks, and foreseeable risk standards, they helped translate medical best practice into clear, defensible obligations for schools and education authorities, reducing ambiguity for duty holders while strengthening protections for children. This legal validation has been pivotal in elevating the ISPAD Position Statements from expert clinical guidance to a globally credible, implementation-ready benchmark, capable of being relied upon by governments, regulators, courts, and school systems to justify training, resourcing, and system-level change in support of students with Type 1 diabetes.